Springworks Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SPRINGWORKS, and when can generic versions of SPRINGWORKS drugs launch?
SPRINGWORKS has one approved drug.
There are twenty-seven US patents protecting SPRINGWORKS drugs.
There are one hundred and two patent family members on SPRINGWORKS drugs in forty-five countries.
Drugs and US Patents for Springworks
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Springworks | OGSIVEO | nirogacestat hydrobromide | TABLET;ORAL | 217677-003 | Apr 4, 2024 | RX | Yes | Yes | 11,820,748 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Springworks | OGSIVEO | nirogacestat hydrobromide | TABLET;ORAL | 217677-002 | Apr 4, 2024 | RX | Yes | No | 10,710,966 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Springworks | OGSIVEO | nirogacestat hydrobromide | TABLET;ORAL | 217677-002 | Apr 4, 2024 | RX | Yes | No | 12,110,277 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Springworks | OGSIVEO | nirogacestat hydrobromide | TABLET;ORAL | 217677-003 | Apr 4, 2024 | RX | Yes | Yes | 11,612,588 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Springworks Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | E399155 | ⤷ Subscribe |
European Patent Office | 4399203 | ⤷ Subscribe |
Guatemala | 200500060 | ⤷ Subscribe |
Peru | 20241326 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.